| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103.4011Z |
| P356 | DOI | 10.1073/PNAS.0510921103 |
| P932 | PMC publication ID | 1449637 |
| P698 | PubMed publication ID | 16537477 |
| P5875 | ResearchGate publication ID | 7242029 |
| P50 | author | Michael P. Snyder | Q28924918 |
| Susan R Compton | Q90287724 | ||
| Barbara M. Willey | Q111076521 | ||
| P2093 | author name string | Jian Wang | |
| Weijun Chen | |||
| Heng Zhu | |||
| Guozhen Liu | |||
| Peng Chen | |||
| Mark Cameron | |||
| Xiaowei Zhu | |||
| Tony Mazzulli | |||
| Shaohui Hu | |||
| Jie Wen | |||
| Qifeng Song | |||
| Andrea Tyler | |||
| Ghil Jona | |||
| Nate Kreiswirth | |||
| P2860 | cites work | Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions | Q24793110 |
| Printing proteins as microarrays for high-throughput function determination | Q28138016 | ||
| Coronavirus as a possible cause of severe acute respiratory syndrome | Q28200848 | ||
| Global analysis of protein activities using proteome chips | Q28209011 | ||
| Receiver operator characteristic (ROC) curves and non-normal data: an empirical study | Q30592662 | ||
| Analysis of yeast protein kinases using protein chips. | Q30955396 | ||
| Disease-specific B Cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens | Q33205152 | ||
| Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong | Q34202150 | ||
| Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay | Q34955252 | ||
| Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study | Q35107638 | ||
| The humanization of N-glycosylation pathways in yeast | Q36026789 | ||
| Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus | Q36600036 | ||
| Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study | Q40557821 | ||
| Antibody to virus components in volunteers experimentally infected with human coronavirus 229E group viruses | Q40614291 | ||
| Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus | Q41005366 | ||
| Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome | Q41005384 | ||
| Detection of human coronavirus 229E-specific antibodies using recombinant fusion proteins | Q41288189 | ||
| Prevalence of antibody to human coronaviruses 229E, OC43 and neonatal calf diarrhea coronavirus (NCDCV) in patients of Northern Italy | Q43588354 | ||
| Coronavirus infection in acute lower respiratory tract disease of infants | Q43833364 | ||
| Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid | Q47293237 | ||
| Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus | Q47877806 | ||
| Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus | Q51642387 | ||
| Early diagnosis of SARS coronavirus infection by real time RT-PCR. | Q51651156 | ||
| A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics | Q74191419 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Coronaviridae | Q1134583 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 4011-4016 | |
| P577 | publication date | 2006-03-07 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray | |
| P478 | volume | 103 |
| Q58244485 | A Highly-Sensitive Colorimetric Assay Method for Antibody Array Based on an Tyramide Signal Amplification System |
| Q89472132 | A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection |
| Q80484073 | A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses |
| Q38691479 | Advancing translational research with next-generation protein microarrays |
| Q36160093 | Antibody-profiling technologies for studying humoral responses to infectious agents |
| Q37214216 | Applications of Functional Protein Microarrays in Basic and Clinical Research |
| Q37325217 | Applications of microarrays in pathogen detection and biodefence |
| Q37598176 | Applications of protein biochips in biomedical and biotechnological research |
| Q35170387 | Applications of protein microarrays for biomarker discovery |
| Q37579765 | Biomarkers of lung-related diseases: current knowledge by proteomic approaches |
| Q38335472 | Characterization of Protein–DNA Interactions Using Protein Microarrays |
| Q35463816 | Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray |
| Q38728681 | Current Experimental Methods for Characterizing Protein-Protein Interactions |
| Q33738002 | Defining the humoral immune response to infectious agents using high-density protein microarrays |
| Q33345618 | Diagnostic investigation of emerging viruses of companion animals |
| Q27025953 | Functional protein microarray as molecular decathlete: a versatile player in clinical proteomics |
| Q37792975 | Functional protein microarray technology |
| Q91910283 | Future Veterinary Diagnostics |
| Q97551111 | Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges |
| Q41763271 | Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays |
| Q38932313 | Global Analysis of SUMO-Binding Proteins Identifies SUMOylation as a Key Regulator of the INO80 Chromatin Remodeling Complex |
| Q33495779 | High quality protein microarray using in situ protein purification |
| Q36211824 | Identification of New Autoantigens for Primary Biliary Cirrhosis Using Human Proteome Microarrays |
| Q35918309 | Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display |
| Q55332215 | Identification of SUMO E3 ligase-specific substrates using the HuProt human proteome microarray. |
| Q34380361 | Identification of antigenic proteins of the nosocomial pathogen Klebsiella pneumoniae |
| Q35882563 | Identifying an immune signature against invasive Salmonella |
| Q37671058 | Interactome Mapping: Using Protein Microarray Technology to Reconstruct Diverse Protein Networks |
| Q36363475 | Leptospiral outer membrane protein microarray, a novel approach to identification of host ligand-binding proteins |
| Q47977505 | Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays |
| Q34204906 | Microarray-based method for screening of immunogenic proteins from bacteria |
| Q36821157 | Microarrays in infection and immunity |
| Q45072132 | Multiplexed Nucleic Acid Programmable Protein Arrays |
| Q37656458 | New Centromere Autoantigens Identified in Systemic Sclerosis Using Centromere Protein Microarrays |
| Q26830244 | Overview of Protein Microarrays |
| Q35195408 | Personal genomes, quantitative dynamic omics and personalized medicine |
| Q37825915 | Personalized medicine - the promised land: are we there yet? |
| Q31077864 | ProCAT: a data analysis approach for protein microarrays |
| Q35497361 | Profiling the Humoral Immune Response of Acute and Chronic Q Fever by Protein Microarray |
| Q24678264 | Protein microarray technology |
| Q33466866 | Protein microarrays |
| Q35002206 | Protein microarrays and biomarkers of infectious disease |
| Q37675495 | Protein microarrays for personalized medicine |
| Q37831719 | Protein microarrays for systems biology |
| Q35109872 | Protein microarrays: novel developments and applications |
| Q38184495 | Proteomic strategies for the discovery of novel diagnostic and therapeutic targets for infectious diseases |
| Q37754857 | Proteomics of lung cell biology and pulmonary disease |
| Q34177041 | Proteomics: Challenges, Techniques and Possibilities to Overcome Biological Sample Complexity |
| Q35770540 | Quantifying Antibody Binding on Protein Microarrays using Microarray Nonlinear Calibration |
| Q34204544 | Rapid identification of novel antigens of Salmonella Enteritidis by microarray-based immunoscreening |
| Q34756073 | Rapid identification of novel immunodominant proteins and characterization of a specific linear epitope of Campylobacter jejuni |
| Q37412509 | Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus. |
| Q97523390 | SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses |
| Q28475008 | Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray |
| Q28473465 | Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia |
| Q40299456 | Serum profiling using protein microarrays to identify disease related antigens |
| Q37334237 | Specific plasma autoantibody reactivity in myelodysplastic syndromes. |
| Q37853185 | Systematic antibody and antigen-based proteomic profiling with microarrays |
| Q34172988 | Yeast proteomics and protein microarrays |
| Q96641709 | [Protein arrays and perspectives of medical applications] |
Search more.